Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on June 11, 2025
Vera Bradley Announces First Quarter Fiscal Year 2026 Results
GlobeNewswire
·
June 11, 2025
First quarter consolidated net revenues totaled $51.7 million Financial condition remains strong with $86 million in liquidity and no debt FORT WAYNE, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the “Company”) today announced …
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 11, 2025
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has …
Alpha Modus Ventures Files Patent Infringement Lawsuit Against Cisco Systems
GlobeNewswire
·
June 11, 2025
CORNELIUS, N.C., June 11, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Ventures, LLC (“AMV”), the entity that recently filed a patent infringement lawsuit against Broadcom Inc. on April 22, 2025, and engaged a patent monetization and funding agreement with Alpha …
ABM Selected to Provide Parking and Shuttle Transportation at Orlando International Airport
GlobeNewswire
·
June 11, 2025
ORLANDO, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of facility, engineering, and infrastructure solutions, has been awarded a new contract by the Greater Orlando Aviation Authority (GOAA) to provide parking and employee …
Kratos Awarded $25 Million Task Order for U.S. Space Force’s Evolved Strategic SATCOM
GlobeNewswire
·
June 11, 2025
SAN DIEGO, June 11, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing
GlobeNewswire
·
June 11, 2025
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On track to report results from three pivotal trials this year, beginning with SUMMIT results in July WALTHAM, Mass. and …
Centrical Wins Workforce Innovation of the Year at the 2025 CCW Excellence Awards
GlobeNewswire
·
June 11, 2025
NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Centrical, the leading AI Performance Experience Platform for frontline teams, was named Workforce Innovation of the Year at the 2025 CCW Excellence Awards. The prestigious awards recognize the most innovative …
Concentrix Schedules Release of Second Quarter 2025 Financial Results and Webcast of Investor Conference Call
GlobeNewswire
·
June 11, 2025
NEWARK, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, plans to announce its fiscal second quarter 2025 financial results after market close on Thursday, June 26, 2025. The Company …
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
GlobeNewswire
·
June 11, 2025
- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation constructs, supporting potential for improved protection …
SailPoint Announces Fiscal First Quarter 2026 Results
GlobeNewswire
·
June 11, 2025
Grew ARR 30% year-over-year to $925 million Increased SaaS ARR 39% year-over-year to $574 million Expanded the number of customers with more than $1 million of ARR by 62% year-over-year AUSTIN, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- SailPoint, Inc. ( …
Victoria’s Secret & Co. Reports First Quarter 2025 Results
GlobeNewswire
·
June 11, 2025
First quarter sales and operating income exceed expectations Reaffirms full year 2025 sales guidance REYNOLDSBURG, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret …
Ligand Announces 2025 Investor Day in New York City
GlobeNewswire
·
June 11, 2025
JUPITER, Fla., June 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 9, 2025 at 10 a.m. Eastern Time at the Harvard Club. The event will …
Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data Highlighting Potential of ITK inhibition to Treat Systemic Sclerosis at EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
SOUTH SAN FRANCISCO, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced preclinical data highlighting the potential of soquelitinib to treat systemic sclerosis …
Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
GlobeNewswire
·
June 11, 2025
MELBOURNE, Australia and INDIANAPOLIS, June 11, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix® (kit for …
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
June 11, 2025
NEWARK, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT), today reported its financial results for the third quarter and first nine months of fiscal year 2025 ended April 30, 2025. “We are pleased to have …
Cabaletta Bio Announces Proposed Public Offering of Securities
GlobeNewswire
·
June 11, 2025
PHILADELPHIA, June 11, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (“Cabaletta” or the “Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically …
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
GlobeNewswire
·
June 11, 2025
– 7 of 8 myositis patients achieved clinically meaningful TIS responses after discontinuation of all immunomodulators, while off or actively tapering steroids; responses were sustained throughout the follow-up period in all responding patients – – All SLE …
Streetleaf Is Now Illuminating Texas
GlobeNewswire
·
June 11, 2025
Dallas, Texas, June 11, 2025 (GLOBE NEWSWIRE) -- Streetleaf, the leading provider of solar-powered streetlight services in the United States, today announced that the company now has a footprint in Texas. The company will now be illuminating streets in …
Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders
GlobeNewswire
·
June 11, 2025
Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existing drugs First start-up company from Argobio’s portfolio to reach a financing milestone – Argobio is an …
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
GlobeNewswire
·
June 11, 2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corporation (NASDAQ: MASI) in relation to …